Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
399,191
-
Share change
-
-35,197,990
-
Total reported value
-
$499,094
-
Price per share
-
$0.05
-
Number of holders
-
11
-
Value change
-
-$41,909,415
-
Number of buys
-
2
-
Number of sells
-
80
Institutional Holders of CLOVIS ONCOLOGY INC - COM (CLVSQ) as of Q4 2022
As of 31 Dec 2022,
CLOVIS ONCOLOGY INC - COM (CLVSQ) was held by
11 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
399,191 shares.
The largest 10 holders included
MACQUARIE GROUP LTD, S&T Bank/PA, WEDBUSH SECURITIES INC, MAI Capital Management, Future Financial Wealth Managment LLC, Newbridge Financial Services Group, Inc., Qube Research & Technologies Ltd, IFP Advisors, Inc, Coppell Advisory Solutions LLC, and Coppell Advisory Solutions Corp..
This page lists
11
institutional shareholders reporting positions in this security
for the Q4 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.